Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood

NCT00639158 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

543

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias
Coronary Heart Disease
Combined (Atherogenic) Dyslipidemia
Mixed Dyslipidemia

Interventions

DRUG: ABT-335
DRUG: placebo
DRUG: atorvastatin
DRUG: ezetimibe

Sponsor

Abbott